Welcome to the Center for Pharmacoepidemiology and Treatment Science
Established on July 1, 2017, the Rutgers Center for Pharmacoepidemiology and Treatment Science (PETS) was formed to perform and foster innovative, multidisciplinary science related to the use and outcomes of therapeutics and diagnostics in large populations. Its mission is to advance pharmacoepidemiology and related fields by conducting world-class research and facilitating high-quality training. The PETS Center brings together a strong team of committed core faculty, highly trained staff, along with colleagues from academia, industry, and regulatory agencies with expertise ranging from epidemiology, biostatistics, and biomedical informatics to clinical medicine, economics, and the social sciences.
News from PETS
Therapy Can Support Medication Treatment for Opioid Use Disorder
Counseling may help keep people in treatment, according to Rutgers study.
Receiving psychosocial and behavioral therapy alongside medications for opioid use disorder leads to better treatment engagement and continuity, according to Rutgers researchers.
Teens and Young Adults Overdosing on Drugs for Common Mental Health Issues
A high number of teens and young adults with an overdose involving a benzodiazepine (BZD), like Xanax, or psychostimulant, like Adderall – medications commonly used to treat mental health issues like attention deficit hyperactivity disorder and anxiety disorders – have a recent medical prescription for a BZD or stimulant, according to Rutgers researchers who say physicians need to weigh the risks and benefits of these medications more closely.
Risk of Severe Allergic Reaction Higher with Two Intravenous Iron-Boosting Products
Five products compared for safety in Rutgers analysis of Medicare database
Two products commonly administered intravenously to replenish iron levels in the body have a much higher chance of provoking a severe allergic attack, according to Rutgers researchers who conducted a study analyzing the medical records in a large database of older, Medicare patients.